Co-Authors
This is a "connection" page, showing publications co-authored by Faraz Bishehsari and Usman Barlass.
Connection Strength
2.399
-
Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases. PLoS One. 2021; 16(1):e0244285.
Score: 0.746
-
Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study. Clin Transl Gastroenterol. 2020 07; 11(7):e00215.
Score: 0.720
-
Correction to: Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Mol Cell Biochem. 2022 May; 477(5):1347.
Score: 0.204
-
Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Mol Cell Biochem. 2022 May; 477(5):1339-1345.
Score: 0.201
-
Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma. Biomedicines. 2021 Jun 23; 9(7).
Score: 0.193
-
Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma. Visc Med. 2020 Jun; 36(3):220-226.
Score: 0.178
-
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation. Int J Cancer. 2018 10 15; 143(8):1994-2007.
Score: 0.158